Trade Names: | |
Synonyms: | |
Status: | Approved (2003) |
Entry Type: | Small molecule |
Molecule Category: | Salt Prodrug |
UNII: | ID1GU2627N |
Parent Compound: | FOSAMPRENAVIR |
InChI Key | PMDQGYMGQKTCSX-HQROKSDRSA-L |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C25H34CaN3O9PS |
Molecular Weight | 623.68 |
AlogP | 2.52 |
Hydrogen Bond Acceptor | 8.0 |
Hydrogen Bond Donor | 4.0 |
Number of Rotational Bond | 13.0 |
Polar Surface Area | 177.72 |
Molecular species | ACID |
Aromatic Rings | 2.0 |
Heavy Atoms | 39.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Human immunodeficiency virus type 1 protease inhibitor | FDA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Laryngopharyngeal Reflux | 3 | D057045 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL1200734 |
EPA CompTox | DTXSID0046777 |
FDA SRS | ID1GU2627N |
PubChem | 131535 |
SureChEMBL | SCHEMBL1649283 |